This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

NPS Pharmaceuticals Inc
NPSP : NASDAQ : Health Care

$24.86 1.48 | 6.33%
Today's Range: 24.30 - 25.45
Avg. Daily Volume: 1,943,600
04/16/14 - 3:21 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
NPSP NPS PHARMACEUTICALS INC 25.15 2597.09 n/m 155.59 19.09
CPHD CEPHEID INC 47.30 3292.03 n/m 401.29 21.15
THRX THERAVANCE INC 28.01 3136.45 n/m 4.76 -96.50
ITMN INTERMUNE INC 28.84 2800.59 n/m 70.34 168.73
MYGN MYRIAD GENETICS INC 38.00 2773.01 16.31 737.12 35.17
GEVA SYNAGEVA BIOPHARMA CORP 79.93 2632.57 n/m 13.37 -10.57
ACAD ACADIA PHARMACEUTICALS INC 20.04 1953.96 n/m 1.15 -76.67
ACOR ACORDA THERAPEUTICS INC 36.93 1525.62 94.69 336.43 10.01
CLDX CELLDEX THERAPEUTICS INC 15.62 1395.77 n/m 4.11 -63.31
ARNA ARENA PHARMACEUTICALS INC 6.18 1355.03 n/m 81.39 195.04
ARIA ARIAD PHARMACEUTICALS INC 7.23 1347.12 n/m 45.56 8065.05
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

NPSP Ind Avg S&P 500
n/m 43.67 18.29
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs